肝脏水胸部:一个审查
Abdellatif Ismail1, Mohanad Awadalla2, Suvisesh Pothuraju3
1Department of Internal Medicine, University of Maryland Medical Center Midtown Campus, Baltimore, MD, USA.
Current hepatology reports
|September 8, 2025
概括
肝脏水胸炎,是不补偿性肝硬化症的严重并发症,预测死亡率. 对肝移植的早期评估可以降低这些患者的移植后死亡率.
科学领域:
- 肝病学 肝病学是一种肝病学.
- 肺部病理学 肺部病理学
- 关键护理医学 关键护理医学
背景情况:
- 肝脏水胸液是肝硬化不补偿的患者的流.
- 它与高发病率和死亡率有关.
- 它发生在没有原发性肺或心肺病理的情况下.
研究的目的:
- 审查肝脏水胸病的流行病学,发病,诊断和管理.
- 突出其作为死亡率预测指标的意义.
- 讨论管理策略,包括肝移植.
主要方法:
- 关于肝脏水胸部现有文献的综述.
- 诊断标准的分析,包括多液分析.
- 评估管理方法和结果.
主要成果:
- 耐火性肝脏水胸腺独立预测了不补偿性肝硬化中的死亡率.
- 肝脏疾病末期病例模型 耐火性肝脏胸水的例外点减少肝移植后的死亡率.
- 致病性涉及流体从腹腔到胸腔的移动,这是由于流体保留.
结论:
- 肝脏水胸病的管理是复杂的,需要一个逐步的,多学科的方法.
- 诊断包括肺部液体分析和排除其他原因.
- 所有耐火性肝脏水胸部患者都需要对肝移植进行评估.
相关概念视频
Esophageal Varices-II: Clinical Features and Management
378
Esophageal varices often manifest as gastrointestinal bleeding episodes, presenting symptoms like hematemesis (vomiting of blood), hematochezia (passing fresh blood via the rectum), and melena (black, tarry stools). Other signs can include weight loss, anorexia, abdominal discomfort, jaundice, pruritus, altered mental status, and muscle cramps.
In the initial assessment, a thorough review of the patient's medical history is vital to identify risk factors such as liver disease, alcohol...
In the initial assessment, a thorough review of the patient's medical history is vital to identify risk factors such as liver disease, alcohol...
378
Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test
185
In clinical practice, the direct measurement of hepatic blood flow to evaluate liver function presents significant challenges due to the intricate and specialized nature of the necessary techniques. Consequently, healthcare professionals often rely on empirical estimates derived from thorough patient examinations and liver function tests to gauge liver health. Among the tools at their disposal, the Child–Pugh and MELD scoring systems stand out for their ability to categorize and assess...
185
Hepatic Portal System
5.4K
The hepatic portal system, a critical part of our circulatory framework, transports nutrient-laden, deoxygenated blood from the gastrointestinal tract and spleen to the liver. This ingenious system plays an indispensable role in maintaining our body's metabolic equilibrium.
At its core, the hepatic portal vein is the result of a confluence of the superior and inferior mesenteric veins along with the splenic vein. Each of these veins has a unique role. The superior mesenteric vein is...
At its core, the hepatic portal vein is the result of a confluence of the superior and inferior mesenteric veins along with the splenic vein. Each of these veins has a unique role. The superior mesenteric vein is...
5.4K
Endoscopic Studies II: Thoracocentesis
1.3K
Thoracentesis(Thoracocentesis), commonly known as pleural tap, is a medical procedure where a 22 gauge needle is inserted into the pleural space, the area between the lung and chest wall. This procedure is commonly performed to diagnose or treat various respiratory disorders.
Description
Excess pleural fluid or air may accumulate in some respiratory disorders in the thoracic cavity. To treat pleural effusion, a physician conducts thoracentesis by carefully piercing the chest wall and entering...
Description
Excess pleural fluid or air may accumulate in some respiratory disorders in the thoracic cavity. To treat pleural effusion, a physician conducts thoracentesis by carefully piercing the chest wall and entering...
1.3K
Effect of Hepatic Disease on Pharmacokinetics: Drug Dosing and Hepatic Blood Flow
217
Chronic liver disease significantly impacts drug metabolism due to alterations in hepatic blood flow and enzyme accessibility. This disruption affects the body's pharmacokinetics—the movement and processing of drugs within the system. Key enzymes crucial for metabolizing medications become less accessible, changing how drugs are processed and utilized. Furthermore, liver disease influences the synthesis of plasma proteins, such as albumin and globulins, which play critical roles in drug...
217


